AIP
CNST

Ameritas Investment Partners’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Ameritas Investment Partners’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,844
Closed -$96K – 3110
2021
Q2 		$96K Buy
2,844
+456
+19% +$11.6K ﹤0.01% 1754
2021
Q1 		$56K Hold
2,388
– – ﹤0.01% 2026
2020
Q4 		$69K Hold
2,388
– – ﹤0.01% 1796
2020
Q3 		$48K Hold
2,388
– – ﹤0.01% 1867
2020
Q2 		$72K Buy
2,388
+743
+45% +$26.8K ﹤0.01% 1611
2020
Q1 		$52K Buy
1,645
+339
+26% +$11.8K ﹤0.01% 1646
2019
Q4 		$62K Hold
1,306
– – ﹤0.01% 1795
2019
Q3 		$8K Hold
1,306
– – ﹤0.01% 2833
2019
Q2 		$16K Hold
1,306
– – ﹤0.01% 2597
2019
Q1 		$18K Buy
1,306
+1,106
+553% +$9.91K ﹤0.01% 2443
2018
Q4 		$1K Hold
200
– – ﹤0.01% 2983
2018
Q3 		$1K Buy
+200
New +$1.91K ﹤0.01% 3018

Ameritas Investment Partners's CNST Position: Q3 2021 in Review

Ameritas Investment Partners sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 2,844 shares — an estimated $96K sold.

Ameritas Investment Partners first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $96K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Ameritas Investment Partners reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,844 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $96K.
  • Ameritas Investment Partners first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
  • Ameritas Investment Partners's Constellation Pharmaceuticals, Inc. position peaked at $96K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Ameritas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.